[The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica (Ephedraceae))]. 2001

M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
Department of Legal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

We investigated false-positive reactions obtained from a drug screening test using a Triage panel. We detected 2 cases giving false-positive reaction for AMP (amphetamine, methamphetamine) during the screening of 187 normal subjects. Subsequent follow up testing by high-performance liquid chromatography (HPLC), showed both to be false-positive reactions. As both cases have a history of ingesting the herbal drug, Ma-huang (Ephedra sinica (Ephedraceae)), containing ephedrine, we examined the relationship between false-positive reactions on Triage and Ma-huang. All urine samples collected from 7 healthy volunteers following administration of Ma-huang indicated AMP positive on Triage. Also a high ratio of AMP positives was observed in the patients who were administered Ma-huang-containing drugs at the hospital. However, none of them were identified as true-positives by HPLC or gas chromatography mass spectrometry (GC/MS) analysis. The extract of Ma-huang contained in herbal drugs, which otherwise contain neither amphetamine nor its derivatives, gives (AMP) positive indications on Triage. We speculate that unidentified components of Ma-huang cause the false-positive reactions. We suggest that follow-up tests by GC/MS or HPLC are needed wherever a positive result is obtained from a screening test by Triage. Furthermore, it will be established to continue collecting information on prescribed and non-prescribed drugs.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
February 1997, Journal of clinical pharmacology,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
January 1996, Journal of analytical toxicology,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
August 1998, Therapeutic drug monitoring,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
March 2011, The journal of the Royal College of Physicians of Edinburgh,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
November 2019, Mitochondrial DNA. Part B, Resources,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
January 2019, Applications in plant sciences,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
December 1998, Journal of pharmaceutical sciences,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
May 2013, Molecules (Basel, Switzerland),
M Nishiguchi, and H Kinoshita, and K Higasa, and T Taniguchi, and H Ouchi, and T Minami, and S Marukawa, and K Yoshinaga, and J Yamauchi, and S Aoki, and S Hishida
October 2019, Mitochondrial DNA. Part B, Resources,
Copied contents to your clipboard!